JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1992; 20:17-23
© 1992 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carney, R.
Right arrow Articles by Teichman, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carney, R.
Right arrow Articles by Teichman, S.

Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarction. RAAMI Study Investigators

RJ Carney, GA Murphy, TR Brandt, PJ Daley, E Pickering, HJ White, TJ McDonough, SK Vermilya, and SL Teichman

Department of Cardiology, Mother Frances Heart Institute, Tyler, Texas 75701.

Clot dissolution with restoration of infarct-related artery blood flow is the likely mechanism for the improved prognosis and mortality reduction seen after thrombolytic therapy of acute myocardial infarction. A pilot study has suggested that 100 mg of recombinant tissue-type plasminogen activator (rt-PA) infused over 90 min may lead to higher patency rates than the current standard of 100 mg over 3 h. In this multicenter, randomized, open label trial, 281 patients with acute myocardial infarction receive 100 mg of rt-PA according to either the standard 3-h infusion regimen (an initial 10-mg bolus followed by 50 mg for the 1st h, then 20 mg/h for 2 h) or an accelerated 90-min regimen (15-mg bolus followed by 50 mg over 30 min, then 35 mg over 60 min). All patients also received intravenous heparin and oral aspirin during and after rt-PA infusion. At 60 min after initiation of the rt-PA infusion, the observed angiographic patency rates were 76% (95% confidence intervals 65% to 84%) in the accelerated regimen group and 63% in the control group (52% to 73%, p = 0.03). At 90 min these rates were 81% (73% to 87%) and 77% (68% to 84%), respectively (p = 0.21). Both randomized groups experienced similar rates of recurrent ischemia, reinfarction, angiographic reocclusion, other complications of myocardial infarction (including stroke and death) and bleeding complications.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
ChestHome page
S. G. Goodman, V. Menon, C. P. Cannon, G. Steg, E. M. Ohman, and R. A. Harrington
Acute ST-Segment Elevation Myocardial Infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 708S - 775S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
V. Menon, R. A. Harrington, J. S. Hochman, C. P. Cannon, S. D. Goodman, R. G. Wilcox, H. J. Schunemann, and E. M. Ohman
Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 549S - 575S.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
T. WALLEY, Y. DUNDAR, R. HILL, and R. DICKSON
Superiority and equivalence in thrombolytic drugs: an interpretation
QJM, February 1, 2003; 96(2): 155 - 160.
[Full Text] [PDF]


Home page
ChestHome page
E. M. Ohman, R. A. Harrington, C. P. Cannon, G. Agnelli, J. A. Cairns, and J.W. Kennedy
Intravenous Thrombolysis in Acute Myocardial Infarction
Chest, January 1, 2001; 119(1_suppl): 253S - 277S.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Garcia, J. Elizaga, N. Perez-Castellano, J. A. Serrano, J. Soriano, M. Abeytua, J. Botas, R. Rubio, E. Lopez de Sa, J. L. Lopez-Sendon, et al.
Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction
J. Am. Coll. Cardiol., March 1, 1999; 33(3): 605 - 611.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R.J. Simes, E. J. Topol, D. R. Holmes Jr, H. D. White, W. R. Rutsch, A. Vahanian, M. L. Simoons, D. Morris, A. Betriu, R. M. Califf, et al.
Link Between the Angiographic Substudy and Mortality Outcomes in a Large Randomized Trial of Myocardial Reperfusion : Importance of Early and Complete Infarct Artery Reperfusion
Circulation, April 1, 1995; 91(7): 1923 - 1928.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
R. M. Prewitt, S. Gu, U. Schick, and J. Ducas
Effect of Rate of Administration of Recombinant Tissue Plasminogen Activator on Efficacy of Coronary Thrombolysis
Angiology, August 1, 1994; 45(8): 687 - 694.
[Abstract] [PDF]


Home page
NEJMHome page
H. Montgomery, M.E. Speechly-Dick, C. Pechlaner, P. Lechleitner, and A. M. Ross
Thrombolytic Therapy for Myocardial Infarction
N. Engl. J. Med., April 14, 1994; 330(15): 1089 - 1090.
[Full Text]


Home page
NEJMHome page
The GUSTO Investigators
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
N. Engl. J. Med., September 2, 1993; 329(10): 673 - 682.
[Abstract] [Full Text]


Home page
NEJMHome page
C. L. Grines, K. F. Browne, J. Marco, D. Rothbaum, G. W. Stone, J. O'Keefe, P. Overlie, B. Donohue, N. Chelliah, G. C. Timmis, et al.
A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction
N. Engl. J. Med., March 11, 1993; 328(10): 673 - 679.
[Abstract] [Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1992 by the American College of Cardiology Foundation.